Lateral flow tests for COVID-19 can be very accurate and specific when used as directed, but introducing acidic fluids can cause the tests’ detecting antibodies to clump, which may read as a positive result.
The Scientist Creative Services Team in collaboration with Thermo Fisher Scientific | 1 min read
Edward Emmott will discuss mass spectrometry approaches to understand proteolysis during viral infection and their use in developing targeted strategies for COVID-19 treatment.
Warm nasal cells mount stronger defenses against cold-causing coronaviruses and rhinoviruses than those exposed to cooler temperatures, an in vitro experiment finds.
A clinical trial finds that the anticoagulant apixaban, which has been prescribed to help COVID-19 patients recover, is ineffective and in rare instances dangerous.
Researchers say they’re abandoning the project in its current form—one of several that aims to induce what’s known as mucosal immunity against SARS-CoV-2.
Recent studies have lent support for a variety of hypotheses explaining the debilitating symptoms affecting millions of people after SARS-CoV-2 infection.